VIVANI MEDICAL INC
VANI · NASDAQ
Updated at 2026-10-13 15:06:24
- Today's High
- $1.20
- Today’s Low
- $1.16
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $1.22
- Previous Close
- $1.19
- Volume
- 146.65K
- Market Cap
- $107.34M
- P/E Ratio
- --
- EPS
- $-0.35
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Health Care
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 1350 SOUTH LOOP ROAD, ALAMEDA, CA, UNITED STATES, 94502
- Country
- US
- Listing Date
- 2014-12-05
- Fiscal Year End
- December
- Shares Outstanding
- 86.24M
- CIK
- 0001266806
- Website
- vivani.com
Vivani Medical Inc. (VANI) is a pioneering biotechnology firm focused on revolutionizing chronic disease management through its cutting-edge drug delivery systems. The company specializes in biocompatible implants that facilitate sustained medication delivery, addressing pressing health challenges, particularly in diabetes and neurological disorders. With a strong product pipeline and an extensive intellectual property portfolio, Vivani is strategically positioned to tackle significant unmet medical needs, presenting an attractive opportunity for institutional investors looking to capitalize on advancements in the biopharmaceutical sector.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$6.87M
2026-03-31
$6.68M
2025-12-31
$6.81M
2025-09-30
$6.72M
Net Income
2026-06-30
-$6.37M
2026-03-31
-$6.78M
2025-12-31
-$6.63M
2025-09-30
-$6.53M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.07
2026-03-31
$-0.08
2025-12-31
$-0.09
2025-09-30
$-0.11
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$7.25M
2026-03-31
-$6.65M
2025-12-31
-$6.51M
2025-09-30
-$6.42M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $6.87M | $6.68M | $6.81M | $6.72M |
| Net Income | -$6.37M | -$6.78M | -$6.63M | -$6.53M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.07 | $-0.08 | $-0.09 | $-0.11 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$7.25M | -$6.65M | -$6.51M | -$6.42M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.